Company profile: Irvine Scientific
1.1 - Company Overview
Company description
- Provider of cell culture media, reagents, and medical devices for researchers and clinicians in bioproduction, vaccines, cell and gene therapies, regenerative medicine, and assisted reproductive technologies. Products include chemically defined CHO, NK, and T cell media, embryo culture oil, DMSO-free cryopreservation, and bone marrow culture media.
Products and services
- BalanCD CHO Media Platform: A chemically defined media platform engineered for CHO cell line growth and productivity in bioproduction, supporting both batch and fed-batch cultures
- PRIME-XV T Cell Expansion XSFM: A xeno-free, serum-free, chemically defined medium architects T cell cultures, supporting the transition from research to clinical production
- PRIME-XV NK Cell CDM: A serum-free, chemically defined medium develops ex vivo NK cell expansion while maintaining their functionality and potency without serum supplementation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Irvine Scientific
SynHelix
HQ: France
Website
- Description: Provider of offerings aimed at breaking the bottleneck of biotherapeutics development by addressing the unsolved DNA constructs supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SynHelix company profile →
ADC Bio
HQ: United Kingdom
Website
- Description: Provider of process technology for antibody drug conjugates (ADCs), helping drug developers address conjugation challenges in testing and production of ADC-based anti-cancer drugs, enabling faster, simpler and lower-cost development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ADC Bio company profile →
Ingenium Pharmaceuticals
HQ: Germany
Website
- Description: Provider of drug development, operating as a subsidiary of Probiodrug AG, an integrated drug development company; founded in 1998 as a spin-off from the German Human Genome Project.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ingenium Pharmaceuticals company profile →
Ansh Labs
HQ: United States
Website
- Description: Provider of immunoassays for research and clinical diagnostics, custom immunoassay development (optimization and validation), monoclonal antibodies, and research reagents (antibodies, antigens, proteins), plus animal-specific assays for veterinary diagnostics. Focus areas include reproductive medicine, neurodegenerative disorders, and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ansh Labs company profile →
Algenex
HQ: Spain
Website
- Description: Provider of vector-based technologies to manufacture recombinant proteins via a baculovirus expression vector system, with applications in vaccines, diagnostic reagents, crystallography, HTS and therapeutic molecules. Offers CrisBio, animal vaccine development/production, and biocomponents for diagnostic and therapeutic markets in human and animal health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Algenex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Irvine Scientific
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Irvine Scientific
2.2 - Growth funds investing in similar companies to Irvine Scientific
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Irvine Scientific
4.2 - Public trading comparable groups for Irvine Scientific
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →